{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T14:29:40Z","timestamp":1770992980820,"version":"3.50.1"},"reference-count":21,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T00:00:00Z","timestamp":1406505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0103495","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T18:13:03Z","timestamp":1406571183000},"page":"e103495","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Decreased Circulating Visfatin Is Associated with Improved Disease Activity in Early Rheumatoid Arthritis: Data from the PERAC Cohort"],"prefix":"10.1371","volume":"9","author":[{"given":"Ond\u0159ej","family":"Sglunda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He\u0159man","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Hulejov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark\u00e9ta","family":"Kuklov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ond\u0159ej","family":"Pecha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenka","family":"Ple\u0161tilov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1ria","family":"Filkov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Pavelka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji\u0159\u00ed","family":"Vencovsk\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ladislav","family":"\u0160enolt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,7,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/MCB.14.2.1431","article-title":"Cloning and characterization of the cDNA encoding a novel human pre-B cell colony-enhancing factor","volume":"14","author":"B Samal","year":"1994","journal-title":"Mol Cell Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1126\/science.1097243","article-title":"Visfatin: a protein secreted by visceral fat that mimics the effects of insulin","volume":"307","author":"A Fukuhara","year":"2005","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/art.22833","article-title":"Pre-B cell colony-enhancing factor\/visfatin, a new marker of inflammation in rheumatoid arthritis with proinflammatory and matrix-degrading activities","volume":"56","author":"F Brentano","year":"2007","journal-title":"Arthritis Rheum"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/art.21942","article-title":"Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis","volume":"54","author":"MA Nowell","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1189\/jlb.0807581","article-title":"Pre-B cell colony-enhancing factor (PBEF)\/visfatin: a novel mediator of innate immunity","volume":"83","author":"T Luk","year":"2008","journal-title":"J Leukoc Biol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/annrheumdis-2011-200646","article-title":"Treatment-specific changes in circulating adipocytokines: a comparison between tumour necrosis factor blockade and glucocorticoid treatment for rheumatoid arthritis","volume":"71","author":"R Klaasen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1136\/annrheumdis-2012-202403","article-title":"Nicotinamide phosphoribosyltransferase\/visfatin expression by inflammatory monocytes mediates arthritis pathogenesis","volume":"72","author":"J Pr\u00e9sumey","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.berh.2008.01.004","article-title":"The role of resident synovial cells in destructive arthritis","volume":"22","author":"C Ospelt","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/ar2418","article-title":"The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?","volume":"10","author":"JS Smolen","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1136\/ard.2005.046540","article-title":"Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis","volume":"65","author":"M Otero","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/art.24626","article-title":"Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis","volume":"60","author":"YH Rho","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref12","first-page":"56","article-title":"Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-alpha therapy","volume":"28","author":"MA Gonzalez-Gay","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/art.30449","article-title":"Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis","volume":"63","author":"IR Klein-Wieringa","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cyto.2011.04.004","article-title":"The level of serum visfatin (PBEF) is associated with total number of B cells in patients with rheumatoid arthritis and decreases following B cell depletion therapy","volume":"55","author":"L Senolt","year":"2011","journal-title":"Cytokine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"D Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2004.029751","article-title":"Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis","volume":"64","author":"JJ Haringman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1007\/s00296-013-2714-3","article-title":"Visfatin and adiponectin as novel markers for evaluation of metabolic disturbance in recently diagnosed rheumatoid arthritis patients","volume":"33","author":"SH El-Hini","year":"2013","journal-title":"Rheumatol Int"},{"key":"ref18","first-page":"311","article-title":"Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis","volume":"26","author":"MA Gonzalez-Gay","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"ref19","first-page":"596","article-title":"High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis","volume":"26","author":"MA Gonzalez-Gay","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/dmrr.1201","article-title":"Visfatin in overweight\/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review","volume":"27","author":"YH Chang","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.62.9.842","article-title":"Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis","volume":"62","author":"M Boers","year":"2003","journal-title":"Ann Rheum Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0103495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T11:33:07Z","timestamp":1540294387000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0103495"}},"subtitle":[],"editor":[{"given":"Oreste","family":"Gualillo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,28]]},"references-count":21,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0103495","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,28]]}}}